Am J Physiol Cell Physiol Ad Instruments
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Cell Physiol (November 26, 2008). doi:10.1152/ajpcell.00514.2008
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
296/2/C221    most recent
00514.2008v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Web of Science (2)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shah, N.
Right arrow Articles by Raufman, J.-P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shah, N.
Right arrow Articles by Raufman, J.-P.
Submitted on October 9, 2008
Revised on November 13, 2008
Accepted on November 19, 2008

Muscarinic receptors and ligands in cancer

Nirish Shah1, Sandeep Khurana1, Kunrong Cheng1, and Jean-Pierre Raufman1*

1 University of Maryland School of Medicine

* To whom correspondence should be addressed. E-mail: jraufman{at}medicine.umaryland.edu.

Emerging evidence indicates that muscarinic receptors and ligands play key roles in regulating cellular proliferation and cancer progression. Both neuronal and non-neuronal acetylcholine production results in neurocrine, paracrine and autocrine promotion of cell proliferation, apoptosis, migration, and other features critical for cancer cell survival and spread. The present review comprises a focused critical analysis of evidence supporting the role of muscarinic receptors and ligands in cancer. Criteria are proposed to validate the biological importance of muscarinic receptor expression, activation, and post-receptor signaling. Likewise, criteria are proposed to validate the role of non-neuronal acetylcholine production in cancer. Dissecting cellular mechanisms necessary for muscarinic receptor activation as well as those needed for acetylcholine production and release will identify multiple novel targets for cancer therapy.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 1977 by the American Physiological Society.